Proscia
<UNKNOWN> · 6 known investors
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.
AI & Machine LearningBiotechHealthtechMedical Devices
Investors · 6
In the news
- On track to diagnose 32,000 patients daily, Proscia is shaping the future of precision medicine | Insight Partnersinsightpartners.com · 2026
- Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine - Prosciaproscia.com · 2025
- Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicineglobenewswire.com · 2025
- Proscia Raises $50M in Fundingfinsmes.com · 2025
- Philadelphia Medical Technology Company, Proscia, Raises $37M Series C Round | BioBuzzbiobuzz.io · 2024
- Proscia's $46M Series C propels AI-driven pathology into the mainstream | VentureBeatventurebeat.com · 2024